The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
A new research program will target biological causes and possible treatments, including anti-psychotic drugs, brain stimulation and hormones.
Antibiotic-resistant bacteria causes 700,000 deaths annually, but there are strategies we can use to slow the rapid rise of these superbugs.
The lack of investment in the development and deployment of decentralised diagnostic devices in Australia, most importantly a COVID-19 nucleic acid test, is a public policy failure.
The rapidly-mutating SARS-CoV-2 virus is testing the resilience of the world’s responses, with some variants evolving to become more infectious, and threatening a third wave.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
Unprecedented efforts are driving the global push for a safe and effective COVID-19 vaccine. Here's how it's likely to be rolled out in Australia.
Dr Erica Tandori, a legally blind artist, is working with biomedical researchers to scale up microscopic life and place it, literally, into people’s hands.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
Dr Harry Al-Wassiti is now part of a Monash research team striving to find a COVID-19 vaccine, but his path has been far from easy.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Never heard of bacteriophages? They're the most abundant biological entity on the planet, and play a vital role in keeping us alive.
Dummy text
